Caffeine Completed Phase 3 Trials for Coronary Artery Disease Diagnostic

IndicationsStatusPurposePhase
CompletedDiagnostic3
clinicaltrials.gov IdentifierTitleDrugs
NCT00826280Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)